The FDA has actually agreed that if we do certain clinical trials, for instance with metformin, the diabetes drug that we think might slow aging, if we can hit certain endpoints and show things are actually working, they are well-prepared to consider calling aging a treatable condition—if not a disease—that we can prescribe medicines for.